The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.
4d
MedPage Today on MSNEmbattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still AheadFor a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of ...
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic ...
6d
Bangkok Post on MSNAortic Valve Stenosis: A Silent, Deadly ThreatAortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...
The benefits of early TAVR for patients with asymptomatic, severe aortic stenosis are consistent regardless of NT-proBNP or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results